Oxford Vaccine

Not many places left for COVID to evade immunity: UK vaccine creator

The expert said that such viruses, by their very nature tend to become less virulent over time, but there is no set timeframe for how long that would take.

published on : 24th September 2021

Single dose of Astrazeneca, Pfizer vaccines cut COVID infection rate significantly, confirms study

Three weeks after people had been given a single dose of either of the vaccine, the rates of all COVID-19 infections fell by 65%.

published on : 23rd April 2021

EU drug regulator confirms AstraZeneca blood clot link but says COVID jab still safe

No specific risk factors, including age, have been identified for thrombosis with the AstraZeneca shot, which could stem from an immune response, the European Medicines Agency (EMA) said.

published on : 7th April 2021

IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for COVID-19

Under IAVI's agreement with Merck KGaA and Serum Institute, the partners will conduct an accelerated, integrated program of preclinical and clinical research to evaluate the antibodies.

published on : 23rd October 2020

If everything goes well India would get COVID-19 vaccine by year-end: Harsh Vardhan

Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.

published on : 24th August 2020